1
Constantine G Boojamra, Lee S Chong, Scott J Hecker, Tomasz W Glinka, Dale E Shuster: Florfenicol-type antibiotics. Schering Plough Animal Health Corporation, May 9, 2006: US07041670 (22 worldwide citation)

The present invention relates to novel florfenicol compounds having the chemical structure: wherein the compounds are useful for the treatment and/or prevention of bacterial infections in a broad range of patients such as, without limitation, birds, fish, shellfish and mammals.


2
David E Junker, Mark D Cochran: Neutralizing GDF8 epitope-based growth enhancing vaccine. Schering Plough Animal Health Corporation, May 13, 2008: US07371726 (16 worldwide citation)

The invention provides new, specific antigenic peptides from the protein GDF8. The invention also provides fusion proteins comprising the new peptides, immunogens and vaccines based on the new peptides and/or fusion proteins, antibodies that specifically bind to the new peptides of GDF8, and methods ...


3
Scott Hecker, Sunil V Pansare, Tomasz W Glinka: Florfenicol prodrug having improved water solubility. Schering Plough Animal Health Corporation, December 26, 2006: US07153842 (11 worldwide citation)

The present invention discloses phosphate esters of florfenicol (prodrugs) and florfenicol analogs having superior water solubility that are hydrolyzed to florfenicol or the respective florfenicol analog in vivo, upon administration to an animal.


4
Dale E Shuster, Scott Hecker, Tomasz W Glinka, Rajeshwar Singh, Zhuoyi Su: Antibacterial 1-(4-mono- and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereof. Schering Plough Animal Health Corporation, April 22, 2008: US07361689 (10 worldwide citation)

Novel florfenicol compounds having the chemical structure: or a pharmaceutically-acceptable salt thereof or a solvate thereof, or prodrug thereof, wherein R1 is CHCl2, CHClF, CHF2, CHBrCl, CH3, CH2N3, CH2CN, CH(R2)NH2 or CH X1X2; where R2 is H, CH3 or CH2OH, and X1 and X2 are independently selected ...


5
Raul E Kohan, Kanwal J Varma, Robert D Simmons, Abu Huq, Keith A Freehauf: Compositions and method for treating infection in cattle and swine. Schering Plough Animal Health Corporation, Robert J Lipka, September 14, 2004: US06790867 (9 worldwide citation)

Novel formulations combining a non-steroidal anti-inflammatory drug (NSAID) such as flunixin, with a fluorinated chloramphenicol or thiamphenicol derivative antibiotic such as florfenicol are disclosed. Methods for using such formulations in the treatment and prevention of infectious diseases of bov ...


6
Steven A Poliska: System and method for collecting, processing and managing livestock data. Schering Plough Animal Health Corporation, Lowenstein Sandler PC, January 16, 2007: US07164361 (6 worldwide citation)

An animal is provided with an identifier for uniquely identifying it. The identifier is entered into a microprocessor-controlled programmable device to start a record for the animal and to record and store information pertaining to the animal into the record. After the recording and storing of infor ...


7
David E Junker, Mark D Cochran: Neutralizing GDF8 epitope-based growth enhancing vaccine. Schering Plough Animal Health Corporation, February 22, 2011: US07892561 (5 worldwide citation)

The invention provides new, specific antigenic peptides from the protein GDF8. The invention also provides fusion proteins comprising the new peptides, immunogens and vaccines based on the new peptides and/or fusion proteins, antibodies that specifically bind to the new peptides of GDF8, and methods ...


8
Adam Gerhard Meyer, Kevin Norman Winzenberg, David G Sawutz, Andris Juris Liepa: Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives. Schering Plough Animal Health Corporation, Kiera A Mathey, Michael D Davis, December 25, 2007: US07312248 (4 worldwide citation)

Novel trifluoromethanesulfonanilide oxime ether compounds useful for controlling endo and/or ectoparasites in the environment are provided, together with methods of making the same, and methods of using the inventive compounds to treat parasite infestations in vivo or ex vivo.


9
David E Junker, Mark D Cochran: Nucleic acids encoding neutralizing GDF8 epitope-based peptides and fusion proteins. Schering Plough Animal Health Corporation, September 8, 2009: US07585648 (4 worldwide citation)

The invention provides new, specific nucleic acids encoding antigenic peptides from the protein GDF8. The invention also provides nucleic acids encoding fusion proteins comprising the new peptides, immunogens and vaccines based on the nucleic acids encoding new peptides and/or fusion proteins, antib ...


10
Mark D Cochran, Stephanie M Cook, Martha A Wild: Recombinant avian herpesvirus useful in vaccine production. Schering Plough Animal Health Corporation, January 1, 2008: US07314715 (4 worldwide citation)

The present invention provides a novel avian herpesvirus (NAHV) vector and recombinant vaccines made therefrom that are useful to immunize avian species against Marek's disease, infectious laryngotracheitis and Newcastle disease. Methods of immunizing an avian species against Marek's disease, infect ...